Topic

Pemazyre (pemigatinib)

A collection of 25 issues

Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in Florida: Complete PA Guide with Forms and Appeals

Answer Box: Quick Path to Pemazyre Coverage in Florida Blue Cross Blue Shield of Florida requires prior authorization for Pemazyre (pemigatinib) based on confirmed FGFR2 fusion/rearrangement testing, prior therapy documentation, and baseline eye exam. Submit PA via Florida Blue provider portal or fax 1-904-348-3295 with genetic test results, pathology

How to Get Pemazyre (pemigatinib) Covered by Aetna (CVS Health) in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Pemazyre Covered in Pennsylvania Pemazyre (pemigatinib) requires prior authorization from Aetna CVS Health for FGFR2 fusion-positive cholangiocarcinoma. In Pennsylvania, you have strong appeal rights including a new state external review program with 50%+ overturn rates. First step today: Have your oncologist submit PA via Aetna's

Renewing Pemazyre (Pemigatinib) Approval with UnitedHealthcare in Ohio: Complete 2025 Renewal Guide

Answer Box: Renewing Pemazyre with UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization renewal for Pemazyre (pemigatinib) every 12 months, with approval based on documented clinical response and absence of disease progression. Submit renewal requests 2-4 weeks before your current authorization expires through the UHC provider portal or by calling 866-889-8054.

Pemazyre (Pemigatinib) Approval with Cigna in Ohio: Answers to the Most Common Questions

Answer Box: Getting Pemazyre Covered by Cigna in Ohio Eligibility: Cigna covers Pemazyre (pemigatinib) with prior authorization for adults with unresectable/metastatic cholangiocarcinoma with FGFR2 fusion/rearrangement after prior systemic therapy, or myeloid/lymphoid neoplasms with FGFR1 rearrangement. Fastest path: Your oncologist submits PA via Cigna provider portal with FGFR

How to Get Pemazyre (pemigatinib) Covered by Humana in North Carolina: Complete Guide to Prior Authorization, Appeals, and Approval

Answer Box: Fastest Path to Pemazyre Coverage Pemazyre (pemigatinib) requires prior authorization from Humana in North Carolina. You'll need documented FGFR2 fusion/rearrangement testing, baseline ophthalmologic monitoring plan, and proof of prior systemic therapy failure. Submit complete documentation through Humana's provider portal for 72-hour standard review.

How to Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Guide with Forms, Appeals, and State Rights

Quick Answer: Getting Pemazyre Approved in North Carolina Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield of North Carolina for FGFR2+ cholangiocarcinoma or FGFR1+ myeloid/lymphoid neoplasms. Your fastest path: submit PA with molecular testing proof, prior therapy documentation, and medical necessity letter through the BCBSNC provider portal.

How to Get Pemazyre (Pemigatinib) Covered by Humana in New York: Complete Forms, Appeals, and Support Guide

Quick Answer: Getting Pemazyre Covered by Humana in New York Pemazyre (pemigatinib) requires prior authorization from Humana in New York. Key requirements: FGFR2 fusion testing report, baseline eye exam, and treatment history documentation. Submit via Humana's provider portal or fax to 877-486-2621. Standard approval takes 7 days; expedited

Myths vs. Facts: Getting Pemazyre (pemigatinib) Covered by Humana in Georgia

Quick Answer: Pemazyre (pemigatinib) is covered by Humana Medicare Advantage plans in Georgia with prior authorization and quantity limits. Common myths include believing all cancer drugs are automatically covered or that Medicare patients can't get financial help. The fastest path to approval: 1) Confirm FGFR2 fusion testing, 2)

How to Get Pemazyre (Pemigatinib) Covered by UnitedHealthcare in Georgia: Appeals Guide and External Review Process

Quick Answer: Getting Pemazyre Covered by UnitedHealthcare in Georgia Yes, you can get Pemazyre (pemigatinib) covered by UnitedHealthcare in Georgia, but it requires prior authorization and molecular testing proof. The fastest path: 1) Ensure your doctor has documented FGFR2 fusion/rearrangement with lab reports, 2) Submit a complete prior authorization

How to Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in New York: Complete Guide with Appeals Process

Quick Answer: Getting Pemazyre Covered in New York Eligibility: Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield for FGFR2+ cholangiocarcinoma or FGFR1+ myeloid/lymphoid neoplasms after prior therapy failure. Fastest path: Submit PA request with FGFR testing results, prior treatment records, and oncologist letter of medical necessity. Start